Tags

Type your tag names separated by a space and hit enter

Clinical characteristics of canine fibrocartilaginous embolic myelopathy (FCE): a systematic review of 393 cases (1973-2013).
Vet Rec. 2016 Dec 24; 179(25):650.VR

Abstract

Fibrocartilaginous embolic myelopathy (FCE) is common in dogs; however, there is conflicting information in the veterinary literature regarding clinical characteristics and data on recovery in severe cases is sparse. A systematic review of canine FCE was performed to delineate the natural history of this disease. 322 previously reported cases and 71 previously unreported cases were identified for inclusion. Source publications were identified via PubMed central search and by references from review articles. Previously unreported cases were identified via computerised medical records search at two veterinary institutions. FCE was most common in middle-aged large breed dogs (30 per cent); however, the miniature schnauzer was the most frequently reported individual breed and small breeds comprised 24 per cent of all reported cases. The most common neuroanatomical localisation was a T3-L3 myelopathy (33.1 per cent). Prognosis for recovery of ambulation was good to excellent with 85 per cent of cases regaining the ability to walk unassisted, most within 3 weeks. Persistent neurological deficits were common in patients that recovered ambulation (49.1 per cent). When nociception was absent in the affected limbs at initial presentation, rate of recovery was lower (10 per cent); however, this data is likely biased by limited follow-up in more severe cases. Future prospective studies should evaluate prognosis for more severely affected patients.

Authors+Show Affiliations

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio 43210, USA.Department of Clinical Sciences, North Carolina State University, Raleigh, North Carolina 27607, USA.Department of Clinical Sciences, North Carolina State University, Raleigh, North Carolina 27607, USA.Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

Pub Type(s)

Journal Article
Review
Systematic Review

Language

eng

PubMed ID

27682506

Citation

Bartholomew, K A., et al. "Clinical Characteristics of Canine Fibrocartilaginous Embolic Myelopathy (FCE): a Systematic Review of 393 Cases (1973-2013)." The Veterinary Record, vol. 179, no. 25, 2016, p. 650.
Bartholomew KA, Stover KE, Olby NJ, et al. Clinical characteristics of canine fibrocartilaginous embolic myelopathy (FCE): a systematic review of 393 cases (1973-2013). Vet Rec. 2016;179(25):650.
Bartholomew, K. A., Stover, K. E., Olby, N. J., & Moore, S. A. (2016). Clinical characteristics of canine fibrocartilaginous embolic myelopathy (FCE): a systematic review of 393 cases (1973-2013). The Veterinary Record, 179(25), 650. https://doi.org/10.1136/vr.103863
Bartholomew KA, et al. Clinical Characteristics of Canine Fibrocartilaginous Embolic Myelopathy (FCE): a Systematic Review of 393 Cases (1973-2013). Vet Rec. 2016 Dec 24;179(25):650. PubMed PMID: 27682506.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical characteristics of canine fibrocartilaginous embolic myelopathy (FCE): a systematic review of 393 cases (1973-2013). AU - Bartholomew,K A, AU - Stover,K E, AU - Olby,N J, AU - Moore,S A, Y1 - 2016/09/28/ PY - 2016/09/11/accepted PY - 2016/9/30/pubmed PY - 2017/5/23/medline PY - 2016/9/30/entrez KW - FCE KW - dog KW - fibrocartilaginous embolic myelopathy KW - ischemic myelopathy KW - spinal cord injury SP - 650 EP - 650 JF - The Veterinary record JO - Vet Rec VL - 179 IS - 25 N2 - Fibrocartilaginous embolic myelopathy (FCE) is common in dogs; however, there is conflicting information in the veterinary literature regarding clinical characteristics and data on recovery in severe cases is sparse. A systematic review of canine FCE was performed to delineate the natural history of this disease. 322 previously reported cases and 71 previously unreported cases were identified for inclusion. Source publications were identified via PubMed central search and by references from review articles. Previously unreported cases were identified via computerised medical records search at two veterinary institutions. FCE was most common in middle-aged large breed dogs (30 per cent); however, the miniature schnauzer was the most frequently reported individual breed and small breeds comprised 24 per cent of all reported cases. The most common neuroanatomical localisation was a T3-L3 myelopathy (33.1 per cent). Prognosis for recovery of ambulation was good to excellent with 85 per cent of cases regaining the ability to walk unassisted, most within 3 weeks. Persistent neurological deficits were common in patients that recovered ambulation (49.1 per cent). When nociception was absent in the affected limbs at initial presentation, rate of recovery was lower (10 per cent); however, this data is likely biased by limited follow-up in more severe cases. Future prospective studies should evaluate prognosis for more severely affected patients. SN - 2042-7670 UR - https://www.unboundmedicine.com/medline/citation/27682506/Clinical_characteristics_of_canine_fibrocartilaginous_embolic_myelopathy__FCE_:_a_systematic_review_of_393_cases__1973_2013__ L2 - https://veterinaryrecord.bmj.com/lookup/pmidlookup?view=long&pmid=27682506 DB - PRIME DP - Unbound Medicine ER -